Avectas, UCD partner on cell engineering

By The Science Advisory Board staff writers

June 3, 2020 -- Avectas and the Simon Laboratory at UC Davis, California (UCD) will work together on cell-engineering technology.

UCD will characterize engineered cells with Avectas' nonviral cell-engineering platform Solupore to inform the development of next-generation cell and gene therapies.

Avectas' platform will be transferred to the Simon Laboratory where they will engineer immune cells and study the delivery of cargoes, like DNA, mRNA, and proteins. They hope the collaboration will aid in the development of new cell and gene therapies.

Copyright © 2020 scienceboard.net

MemberID or email address:  

Forgot your password?